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Abstract: The COVID-19 pandemic caused a health crisis on an unprecedented scale, due to the unstoppable spread of the 
disease through the global integration provided by the current strongly globalized society. Isolation policies recommended by 
WHO impacted countries economies, making it necessary to implement a range of economic, health, social and economic 
security policies,  such as: financial aid packages for the population and companies, investment of resources for the structuring 
of hospital beds for the treatment of patients, implementation of population testing programs, among others. The impact of the 
pandemic proved to be quite significant especially for the so-called "developing countries", due to the difficulties in establishing 
the aforementioned range of security policies as well as mass testing of the population in order to reliably map the disease 
spreading. The implementation of those measure were limited not only by economic reasons, but also by political impediments. 
In the present study, a Bayesian analysis of the immunization rate against COVID-19 through vaccination, evaluating the 
immunization scenarios lasting or temporary. The logistics required for the vaccination campaign in Brazil were assessed by 
considering uncertainties in determining the daily rate of immunization, as well as the effectiveness of the vaccine made 
available for the population. In this intent, an epidemiological model was used compartmentalized, calibrated against historical 
data using the CATMIP stochastic algorithm. The obtained results indicate that the daily vaccination rate is the most important 
parameter of a successful immunization program, given an effectiveness rate equal or superior to 50%. However, a massive 
immunization rate needs to be conjugated with a responsible relaxing of the social distancing measures after the vaccination 
program start, under the risk of compromising any positive result in terms of the number of contaminated and deceased 
individuals.   
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1. INTRODUCTION 
The COVID-19 is a pandemic that has spread rapidly in almost the totality of the countries of the world, arising serious 
concerns in the sanitary authorities and in the society in general. Even one year after the first case in the Chinese city 
of Wuhan, several countries still present epidemiological data that are not at all reliable, considering the lack of 
population mass testing capacity (especially in the so called "developing countries"), as well as clinical characteristics 
intrinsic to the disease, which include long incubation period with symptoms absence and a great number of 
asymptomatic carriers (1-3). Those inconsistencies are translated in uncertainties in the epidemiological data, which 
need to be considered during the task of modeling the disease spreading process, especially for future scenario 
projections.     
After the Brazilian population witnessed an escalation in the number of deaths due to COVID-19, which proved to be 
subsidized by the difficulty in establishing the effective social distance and prophylactic care as frequent hand hygiene, 
and most recently the low vaccination rate. Those measures consist of the only concrete measures for coping with 
the disease in the present moment, considering the nonexistence of a pharmacological treatment for it according to 
the World Health Organization (WHO), although part of the Brazilian institutions have endorsed the use of drugs 
without proper support from the authorities competent medical practitioners. However, the development and 
availability of vaccines for coping of the disease - an unprecedented feat in science in terms of its speed - presents 
itself as a reliable alternative for coping with COVID-19. In this sense, there are two uncertainties regarding the 
immunization response vaccination: the logistical capacity of provide immunization for the population, and the duration 
of immunization provided by it. The present work aims to develop a modeling for the process of transmission of 
COVID-19 considering the uncertainties from the registration of epidemiological data and analyze scenarios for the 
variables already mentioned in regards vaccination. 
2. METHODOLOGY 
2.1 Epidemiological modeling of the problem 
In modeling the COVID-19 transmission process in the country a compartmentalized epidemiological model was used, 
based in the work of (1, 2, 4) with the consideration of social distance between individuals. Thus, individuals can be 
divided into the following compartments: susceptible (S) to infection; exposed (E), the which have had contact with 
the viral agent and will become carriers of the virus (symptomatic or not); infected symptomatic (I), although not yet 
officially detected as contaminated; asymptomatic infected (A), which have low viral load and therefore symptoms 
that do not justify the search for medical care, even though they are capable of transmitting the disease; infected 
individuals tested (T), who are assumed to have sought medical care, since the expressive majority of tests in the 
country are carried out only when such a situation occurs; individuals already recovered (R), who managed to recover 
from the disease and remain immune to it for a certain period of time; individuals who died (D) as a result of disease 
and/or its complications; individuals immunized by vaccination (V), which require an specific amount of time for 
developing immunological capabilities against the Sars-CoV-2 virus, and will remain immune to the disease until that 
immunity is reduced below a critical value. The model was called MOSVAC (SEIARD model with Vaccination), which 
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The relevant parameters for MOSVAC model are presented in the Table 1, in which the meaning of each one in the 
compartmentalized modeling context is presented. It is important to notice that it is assumed that the possibility for 
the transmission of the disease from the vaccinated individual during the time of proper immunity development, as 
suggested by sanitary authorities (5). 
Table 1. MOSVAC model parameters and their respective meanings, along with values and units, when relevant. 
Parameter Value Units Meaning 
𝛽 Calibrated 𝑑𝑎𝑦𝑠−1 Daily rate of effective contacts for disease transmission 
𝜈 1/5 𝑑𝑎𝑦𝑠−1 Inverse of the time for symptomatic manifestation 
𝜅 1 - 
Proportionality factor between for asymptomatic and symptomatic individuals  
contact rate 
𝛾𝐼 = 𝛾𝑇 , 𝛾𝐴 Calibrated; 1/14 𝑑𝑎𝑦𝑠
−1 Inverse of the time for recovery from the disease 
𝜂𝐼 = 𝜂𝑇 0.1% 𝑑𝑎𝑦𝑠
−1 Disease daily fatality rate 
𝜎 Calibrated 𝑑𝑎𝑦𝑠−1 Daily rate of social distancing 
𝜌 85% - Percentage of symptomatic carriers 
𝜖𝐼 = 𝜖𝑇 , 𝜖𝐴 Calibrated; 1/5 𝑑𝑎𝑦𝑠
−1 Inverse of the time for disease detecting through testing 
𝛬(𝑉) 0 or 1 - Parameter for signaling the occurrence (1) or absence (0)  of vaccination  
𝛹 Projected 𝑑𝑎𝑦𝑠−1 Immunization   effectivity through vaccination 
𝛷 Projected 𝑑𝑎𝑦𝑠−1 Daily rate of immunization of individuals 
𝜃𝑉 Projected 𝑑𝑎𝑦𝑠
−1 
Inverse of the time necessary for the disease immunity acquired from vaccination 
drops below critical limit 
𝜃𝑅  Calibrated 𝑑𝑎𝑦𝑠
−1 
Inverse of the time necessary for the acquired disease immunity without 
vaccination drops below critical limit 
𝜆 1/30 𝑑𝑎𝑦𝑠−1 Inverse of the time necessary for the development of immunity through vaccination 
𝑁 2.09 x 108 𝑑𝑎𝑦𝑠−1 Brazilian population size 
 
2.2 Bayesian calibration 
Once the possible model uncertainties are accounted for the parameters of the model, the simple parameter 
estimation (or inference) is replaced by the Bayesian parameter inference, a process also known as Bayesian model 
calibration. In this intent, the robust Python probabilistic programming package pymc3 was employed (6), through the 
utilization of the Cascading Adaptive Transitional Metropolis in Parallel (CATMIP)  algorithm (7), member of the 
Sequential Monte Carlo (SMC) family of techniques (8, 9). In general terms, the method consists in a population-
based Monte Carlo method that relies in the iterative process of sampling and re-sampling candidate probability 
distributions which will asymptotically converge the density function of the function under study, according to a 
simulated annealing process that will converge the transitional probability kernels to a desired probability distribution 
through a finite number of iterative steps (9, 10). The interested reader is referred to the works of (7, 11, 12) for the 
thoroughly description of the process and the underlying statistical concepts. 
The Bayesian calibration process was carried out considering the parameters to be calibrated from the MOSVAC 
model (namely 𝛽, 𝜎, 𝛾𝐼 , 𝜂𝐼 , 𝜃𝑅) as stochastic parameters, whose uncertainty stems from the compromise of information 
due to factors such as under-reporting, lack of testing mass production on a significant scale for the population, among 
other factors. In general terms, the mathematical description of the process consists of calibrating the set of 
parameters given the observations y, thus determining the uncertainties most likely for the calibrated parameters, 
resulting in a posteriori probability distribution. Such a process can be described presented from a point of view 
stochastic in Equation 9, according to the Bayes rule (4). 
𝑷𝒑(𝒑~∨ 𝒚) = 𝑷𝒑𝒓(𝒑~)
𝑷𝒍(𝒚∨𝒑~)
𝑷𝒆(𝒚)
  (9) 
In the Equation 9, the terms 𝑷𝒑, 𝑷𝒑𝒓, 𝑷𝒍, 𝑷𝒆represent respectively: the posterior probability distribution; the a priori 
(initially defined) probability distribution regarding 𝒑~, defined as uniformly distributed variables as prior knowledge; 
the likelihood function that measures the goodness of fit of a supposed statistical model to describe the observed 
data, given the model parameters; and the information encompassed in the data. Only the data regarding the 
positively diagnosed and deceased individuals (respectively T and D in the MOSVAC model) were used in the 
calibration, and it is assumed that the uncertainties regarding those data subsets (the stochastic parameters of the 
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model, namely 𝜷,𝝈, 𝜸𝑰, 𝜼𝑰, 𝜽𝑹) follows a Gaussian distribution with standard deviations sT² and sD², respectively. 
Hence, the likelihood function employed in the calibration process is presented in the Equation 10. 
𝑷𝒑(𝒑~∨ 𝒚) = 𝑷𝒑𝒓(𝒑~)
𝑷𝒍(𝒚∨𝒑~)
𝑷𝒆(𝒚)
  (10) 
In the aforementioned equation, the parameters𝒑~represent the unobserved random variables, defined as uniformly 
distributed a priori. In a similar way, the standard-deviation presumed for the epidemiological data is also considered 
as a random variable, being defined empirically through the aforementioned method. The calculation of the 
accumulated of the data for comparison with the official epidemiological information registered for the number of 
diagnosed cases and deceases (TTOT and DTOT, respectively) are assessed through the Equations 11-12. Those 
values represent the model output, which the CATMIP routine employs for the comparison with the historical data. 








2.3 Establishment of immunization scenarios for study 
Considering that the values for stochastic parameters of the model are determined in the form of a posterior distribution 
probability, using the available epidemiological data during the observed time interval, the model responses can be 
inferred for different values of the working variables in the context of a vaccination immunization program in the country. 
In the present work, the following variables were adopted: the effectiveness of immunization through vaccination (𝛹), 
which may be affected by the lacking of immunizing agent for application of two doses treatment when necessary, or 
improper handling of those; daily individual immunization rate (𝛷); the necessary time for the immunization conferred 
by the vaccination is reduced to a value below the critical limit (𝜃𝑉), causing the individual to become again susceptible 
to contamination. Those variables were divided into two different levels (optimistic, pessimistic), and the immunization 
scenarios were obtained for each one of the variables, resulting in the 8 different parameter configurations presented in 
the Table 2. This parametric scheme is equivalent to experimental design of two levels with two factors (2³), although 
lacking its theoretical framework in terms of the result analysis. 
The values referring to optimistic and pessimistic scenarios for the study variables are presented in the Table 3. It is 
worth to mention that the duration time for immunity acquired through vaccination (𝜃𝑉
−1) was presented, with the intent 
to obtain a more informative value with unit in 𝑑𝑎𝑦𝑠. It is worth to mention that in the determination of the daily 
immunization rate (𝛷), it was considered that 50% of the planned monthly produced value is made available to 
vaccination sites as an optimistic value, whilst the pessimistic value is assumed to be 1% of this quantitative. 
The simulation of the compartmentalized model presented in the Equations 1-8 consisted in the substrate for the 
realization of the model calibration process, as aforementioned. All the numerical simulations were performed through 
the Python computational language library for numerical tasks, the scipy (16), using the function ivp_solve, that provides 
several integrative robust solvers for solution of the incidental initial value problems. In the present work, the LSODA 
routine (17) was employed in this intent, which has adaptive order variation, being referred as a reliable method for 
resolution of numerical stiff problems. The model parameter values presented in the Table 1 were used in the 
simulations. The epidemiological data employed for model calibration were obtained through CSSE (Johns Hopkins 
University Center for Systems Science and Engineering) through its repository on Github platform.  
Table 2 .Immunization scenarios employed in the present work in terms of the study variable levels. The symbols P 
and O represent pessimistic and optimistic levels, respectively. 
Scenario number 𝛹 level 𝛷 level 𝜃𝑉 level 
1 P P P 
2 O P P 
3 P O P 
4 O O P 
5 P P O 
6 O P O 
7 P O O 
8 O O O 
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Table 3. Nominal values for optimistic and pessimistic scenarios  for study variables 
Parameter Optimistic value Pessimistic value 
1 1095  𝑑𝑎𝑦𝑠 (13) 90  𝑑𝑎𝑦𝑠 






3. RESULTS AND DISCUSSION 
3.1 Model calibration 
The results obtained for the calibration of the stochastic model are presented in terms of the posterior probabilities of 
the parameters for which the uncertainties was considered, as presented in the Figures 1-5. In the simulations, it was 




Figure 1. Frequency histogram for the calibrated parameter 𝛽. 





Figure 2. Frequency histogram for the calibrated parameter 𝛾𝐼. 
 
Figure 3. Frequency histogram for the calibrated parameter 𝜖𝐼. 




In the Figures 1-5, it is possible to notice that the standard deviation of the calibrated parameters is relatively low, as 
indicated by the histograms with diminished narrow total amplitude. This fact can be explained by the fact that the 
model is being calibrated with a historical dataset with a large time interval (from the first detected case date in Brazil, 
02/26/20, to 01/12/21), unlike the data presented in the literature (4, 18).  
3.2 Study of the immunization scenarios 
In the Figures 6-7, it is possible to observe the narrow amplitude of the obtained 95% confidence interval for the model 
outputs, which can be also linked to the aforementioned extension of the historical dataset used in the model 
calibration. The stability observed in the output for both scenario groups (𝜣𝑽optimistic and pessimistic) can be 
explained by the influence of the social distancing parameter (𝝈), which "dampens" the impacts caused by the 
reduction of the duration of immunity acquired through vaccination, as well as the diminishing of the acquired immunity 
through disease recovery without vaccination. Nevertheless, it is important to mention that the  number of disease 
 
Figure 4. Frequency histogram for the calibrated parameter 𝜎. 
 
Figure 5. Frequency histogram for the calibrated parameter 𝜃𝑅 . 
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fatal victims can reach up to 600k individuals (circa January/2023) in the scenarios with pessimistic immunization 
daily rate (𝜱) or vaccine effectiveness (𝜳), assuming a required period of 30 days for proper development of the 
disease immunity through vaccination (period after which the individual can no longer be contaminated or transmit 
the disease) and the maintenance of the social distancing scenario assessed through the historical data. 
 
 
Figure 6 .Projected data using the MOSVAC model, for a optimistic 𝜃𝑅scenario and multiple scenarios of 𝛹,𝛷(from 
the left to the right, and from top to bottom, scenarios number 5, 6, 7 and 8). The social distancing measures were 
assumed to be maintained after the start of the immunization program. 
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In the Figures 8-9, the results were projected for the same configuration of scenario groups (optimistic and pessimistic 
values for 𝜣𝑽, respectively) for an abrupt removal of the social distancing measures. The projected results exhibits 
an expected dampened oscillatory behavior in the contamination of individuals, which led to the utilization of the more 
robust numerical integration method BDF (19) for projection of the scenario results. In a epidemiological sense, the 
oscillations obtained with the abrupt interruption of the social distancing measures represent periods of disease 
transmission heightening, resulting in a unbridled escalation of the individuals contaminated and deceased individuals 
due to COVID-19. Those results overcome significantly the benefits of the vaccination for all scenarios, even for the 
optimistic projection of both the immunization daily rate and effectivity. 
 
Figure 7. Projected data using the MOSVAC model, for a pessimistic 𝜃𝑅scenario and multiple scenarios of 𝛹,𝛷(from 
the left to the right, and from top to bottom, scenarios number 1, 2, 3 and 4). The social distancing measures were 
assumed to be maintained after the start of the immunization program. 





Figure 8. Projected data using the MOSVAC model, for a optimistic 𝜃𝑅scenario and multiple scenarios of 𝛹,𝛷(from 
the left to the right, and from top to bottom, scenarios number 5, 6, 7 and 8). The social distancing measures were 
assumed to be abruptly interrupted after the start of the immunization program. 
Figure 9.  Projected data using the MOSVAC model, for a pessimistic𝜃𝑅scenario and multiple scenarios of 
𝛹,𝛷(from the left to the right, and from top to bottom, scenarios number 1, 2, 3 and 4). The social distancing 
measures were assumed to be abruptly interrupted after the start of the immunization program. 
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4. CONCLUSION 
In the present work the calibration of a compartmentalized epidemiological model with stochastic components for the 
COVID-19 spreading process were performed - the so called MOSVAC model - through the utilization of CATMIP 
probabilistic algorithm.  The model output exhibited good agreement with the historical data, which demonstrates  the 
algorithm robustness. It is worth to emphasize the great influence of the social distancing parameter(𝜎)in the results 
obtained after the immunization program start. An abrupt interruption of the social distancing(𝜎 = 0)implies in a vertiginous 
escalation in both contaminated and deceased individuals numbers, exhibiting a oscillatory response that represent 
epidemiological cycles of reinfection. However, it is important to recognize that all mathematical models are somewhat 
limited, and the present projections should be considered rather in a qualitative than quantitative aspect. Despite this 
inherent limitation, it is evident that the Brazilian strategy for coping with the COVID-19 pandemic need to establish a 
massive immunization campaign with significant daily vaccination rates, which seems to be much more decisive than the 
vaccine effectiveness for the considered scenarios(𝛹 ≥ 50%). Ultimately, the decisive factor for a successful campaign 
for the disease mitigation relies in the establishment of the conjugation of responsible social distancing relaxing measures, 
constant with the massive immunization of the population. Only the synergy between those aspects could lead us to the 
proper recovery route from the nefarious effects of the pandemic in Brazil. 
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